Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells
- PMID: 17492365
- DOI: 10.1007/s11095-007-9320-6
Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells
Abstract
Purpose: Some methoxyflavones (MFs) are known to inhibit the function of P-glycoprotein. The aim of this study is to characterize the reversal of multidrug resistance (MDR) by MFs.
Methods: The effects of 19 MFs, including 3,5,6,7,8,3',4'-heptamethoxyflavone, nobiletin, and tangeretin, and flavone on the uptake of [3H]vincristine into an adriamycin-resistant variant of human chronic myelogenous leukemia (K562/ADM) cells were investigated. Potentiation of vincristine-induced growth inhibition by these MFs was also tested in K562/ADM cells by means of WST-1 [2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium] assay.
Results: All MFs (20 microM) tested increased the uptake of [3H]vincristine. 3,5,6,7,8,3',4'-heptamethoxyflavone, nobiletin, tangeretin, quercetagetin and quercetin pentamethylether showed especially potent effects. The increase in the uptake of [3H]vincristine was proportional to the number of methoxyl moieties. While substitution with a methoxyl moiety at the C3 position was the most influential, methoxyl substitution at both the C3' and C5' positions resulted in a decrease in the potentiation of uptake. Furthermore, there was a significant correlation between the potencies for increasing [3H]vincristine uptake and for growth inhibition assessed by WST-1 assay.
Conclusions: MFs increased the uptake of [3H]vincristine into MDR cells and exhibited MDR-reversing effects. Their potencies were influenced by the number and positions of the methoxyl moieties.
Similar articles
-
Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.Cancer Lett. 2002 Mar 8;177(1):89-93. doi: 10.1016/s0304-3835(01)00761-3. Cancer Lett. 2002. PMID: 11809535
-
Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.Cancer Lett. 2000 Nov 10;160(1):21-8. doi: 10.1016/s0304-3835(00)00549-8. Cancer Lett. 2000. PMID: 11098080
-
Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.Eur J Pharmacol. 2008 Apr 14;584(1):66-71. doi: 10.1016/j.ejphar.2008.01.039. Epub 2008 Feb 5. Eur J Pharmacol. 2008. PMID: 18304528
-
Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.Tumour Biol. 2016 Jul;37(7):8587-97. doi: 10.1007/s13277-015-4478-8. Epub 2016 Jan 6. Tumour Biol. 2016. PMID: 26733176
-
Synthesis, structure-activity relationship and biological activity of acridine derivatives as potent MDR-reversing agents.Curr Med Chem. 2013;20(32):4070-9. doi: 10.2174/09298673113209990187. Curr Med Chem. 2013. PMID: 23895691 Review.
Cited by
-
Proteomics-based network pharmacology and molecular docking reveal the potential mechanisms of 5,6,7,4'-tetramethoxyflavone against HeLa cancer cells.Heliyon. 2024 Oct 4;10(20):e38951. doi: 10.1016/j.heliyon.2024.e38951. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39449708 Free PMC article.
-
Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.J Clin Lab Anal. 2013 Jan;27(1):62-71. doi: 10.1002/jcla.21563. Epub 2013 Jan 4. J Clin Lab Anal. 2013. PMID: 23292860 Free PMC article. Review.
-
Biopharmaceutical Study on Nobiletin-Loaded Amorphous Solid Dispersion with Improved Hypouricemic Effect.Molecules. 2021 Jul 23;26(15):4447. doi: 10.3390/molecules26154447. Molecules. 2021. PMID: 34361599 Free PMC article.
-
Flavonoids as Chemosensitizers in Leukemias.Adv Exp Med Biol. 2025;1479:205-234. doi: 10.1007/5584_2024_828. Adv Exp Med Biol. 2025. PMID: 39503945 Review.
-
Phytochemicals: Potential Lead Molecules for MDR Reversal.Front Pharmacol. 2020 Jun 19;11:832. doi: 10.3389/fphar.2020.00832. eCollection 2020. Front Pharmacol. 2020. PMID: 32636741 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous